Overview
- Federal prosecutors announced the case Wednesday, citing a Dec. 5 complaint that says she provided the products to three Chicago patients in 2023.
- The items were labeled as Ozempic yet were not manufactured by Novo Nordisk and contained no semaglutide, prosecutors said.
- Sharon Charitine Sackman is charged with one count of distributing misbranded drugs and three counts of dispensing counterfeit drugs.
- Each count carries a potential sentence of up to one year in federal prison upon conviction.
- Prosecutors say the registered nurse, who lives in Playa del Carmen, Mexico, lacked authority to prescribe or sell Ozempic; the Feb. 3 status hearing is before U.S. Magistrate Judge Laura K. McNally.